|
Comparing COVID-19 Vaccines: Timelines, Types and Prices: Feb 08, 2021
[BioSpace]:Pfizer-BioNTech Type: mRNA Doses: 2, 21 Days Apart EUA Date: December 11, 2020 Price: $19.50 per dose for first 100 million doses Efficacy: About 95%. Apparently 100% at preventing hospitalization and death. Variants: Lab data suggest "quite effective" against the UK variant as well as the South African and Latin American variants. Moderna Type: mRNA Doses: 2, 28 Days Apart EUA Date: December 18, 2020 Price: $25-$37 per dose Efficacy: About 95%. Apparently 100% at preventing hospitalization and death. Variants: Lab data suggest "quite effective" against the UK variant as well as the South African and Latin American variants. AstraZeneca-University of Oxford Type: Adenovirus-based Doses: 2, 28 Days Apart Likely EUA Date: Authorized in Europe on January 12, 2021, and other countries, but unlikely in the U.S. until spring Price: $2.15 (U.S.) in the EU; $3-4 (U.S.) in the UK and U.S.; $5.25 (U.S.) in South Africa Efficacy: Currently about 70% overall. Variants: At least one study finds it has little effect against the South African variant, but appears effective against UK and Brazilian variants. Johnson & Johnson Type: Adenovirus-based Doses: 1 Authorized Price: $10 per dose Efficacy: In J&J’s global clinical trial, it demonstrated 66% efficacy at preventing symptomatic COVID-19 infections. In the U.S. it was slightly higher, 72%. Appears to be 100% effective at preventing hospitalizations and death. Variants: Based on clinical studies in Africa, UK and Latin America, there is evidence the vaccine is effective against the variants, although less so against the South African and Latin American strains. Exaggerated reports re side-effects for the last two. Any questions? Posted by: g(r)omgoru 2021-04-15 |
| http://www.rantburg.com/poparticle.php?ID=599579 |